Understanding regenerative medicine care in Korea
Regenerative medicine is an umbrella term, not a single treatment with one level of evidence. Before considering an intervention in Korea, ask for the exact product, cell or tissue source, route of administration and proposed indication. Availability at a clinic does not establish that the intervention is effective or authorized for your condition. Compare the evidence and Korean regulatory status for the specific use, and distinguish established care from research or commercial marketing. The directory helps you identify providers to question; it is not an endorsement of every advertised regenerative service.
What exactly is being offered?
Ask the provider to name the product and explain how it is obtained, processed and administered. Terms such as stem cells, exosomes, immune therapy and regeneration can describe very different interventions. Request the proposed indication in writing, together with the responsible clinician and the clinical setting. If your own cells are used, that fact alone does not settle questions about safety, effectiveness or regulatory requirements. A treatment plan should be understandable without relying on a brand name, a biological metaphor or a claim about rejuvenation in general.
What evidence and authorization apply to your condition?
Ask for studies involving the same intervention and a patient group comparable to yours. Distinguish laboratory findings, early research and controlled clinical evidence. Discuss the size and duration of any expected benefit, uncertainty and alternatives with an appropriately qualified clinician. Ask which Korean authority has authorized the product or clinical trial for the proposed use. Regulatory decisions in another country do not automatically establish Korean status, and authorization for one condition does not establish benefit for unrelated illnesses or general anti-aging claims.
What follow-up and financial commitments should be clear?
Ask about known harms, infection controls, monitoring and the plan if your condition worsens or the expected benefit does not occur. Clarify who handles adverse events after you leave Korea and whether long-term follow-up is needed. Obtain a written account of all costs, including repeat administrations and testing. Do not replace established care or delay necessary treatment based on an unverified promise. For a serious condition, an independent specialist opinion can help assess whether the proposed intervention has a credible role in your overall care.
